📣 VC round data is live. Check it out!
- Public Comps
- SonoScape
SonoScape Valuation Multiples
Discover revenue and EBITDA valuation multiples for SonoScape and similar public comparables like Sinocare, Tandem Diabetes Care, Enovis, Daan Gene and more.
SonoScape Overview
About SonoScape
Sonoscape Medical Corp is a Chinese manufacturer of medical devices for ultrasound diagnostic systems and transducers. The company's product categories include Ultrasound, Endoscope which also includes video equipment, and Electrocardiography consisting of veterinary ECG and resting ECG. Ultrasound category covers color Doppler trolley systems, color Doppler HCU, B/W trolley systems, and probe, among others. The organization has a business presence in China and in other countries.
Founded
2002
HQ

Employees
N/A
Website
Financials (LTM)
EV
$1B
Valuation Multiples
Start free trialSonoScape Financials
SonoScape reported last 12-month revenue of $360M and EBITDA of $45M.
In the same LTM period, SonoScape generated $225M in gross profit, $45M in EBITDA, and $38M in net income.
Revenue (LTM)
SonoScape P&L
In the most recent fiscal year, SonoScape reported revenue of $341M and EBITDA of $40M.
SonoScape is profitable as of last fiscal year, with gross margin of 62%, EBITDA margin of 12%, and net margin of 9%.
Financial data powered by Morningstar, Inc.
SonoScape Stock Performance
SonoScape has current market cap of $1B, and enterprise value of $1B.
Market Cap Evolution
SonoScape's stock price is $3.02.
SonoScape share price increased by 0.4% in the last 30 days, and decreased by 30.0% in the last year.
SonoScape has an EPS (earnings per share) of $0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1B | $1B | -0.7% | 0.4% | -19.4% | -30.0% | $0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSonoScape Valuation Multiples
SonoScape trades at 3.1x EV/Revenue multiple, and 24.6x EV/EBITDA.
EV / Revenue (LTM)
SonoScape Financial Valuation Multiples
As of June 3, 2026, SonoScape has market cap of $1B and EV of $1B.
SonoScape has a P/E ratio of 33.8x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SonoScape Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


SonoScape Margins & Growth Rates
SonoScape grew revenue by 15% and EBITDA by 55% in the last fiscal year.
In the most recent fiscal year, SonoScape reported gross margin of 62%, EBITDA margin of 12%, and net margin of 9%.
SonoScape Margins
SonoScape Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
SonoScape Operational KPIs
SonoScape's Rule of 40 is 30% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
SonoScape's Rule of X is 52% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
SonoScape Competitors
SonoScape competitors include Sinocare, Tandem Diabetes Care, Enovis, Daan Gene, AtriCure, AdaptHealth, NeoGenomics, Wandong Medical, Integra Lifesciences and VCANBIO.
Most SonoScape public comparables operate across Medical Devices, Medical Imaging & Diagnostics, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.9x | 1.8x | 22.4x | 17.2x | |||
| 1.4x | 1.4x | (31.2x) | (430.9x) | |||
| 1.2x | 1.2x | 6.6x | 6.4x | |||
| 10.4x | - | (17.3x) | - | |||
| 2.3x | 2.2x | 20.0x | 17.7x | |||
| 1.0x | 1.0x | 5.3x | 5.0x | |||
| 2.2x | 2.1x | 36.4x | 32.4x | |||
| 4.5x | 4.3x | (24.0x) | - | |||
This data is available for Pro users. Sign up to see all SonoScape competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SonoScape
| When was SonoScape founded? | SonoScape was founded in 2002. |
| Where is SonoScape headquartered? | SonoScape is headquartered in China. |
| Is SonoScape publicly listed? | Yes, SonoScape is a public company listed on Shenzhen Stock Exchange. |
| What is the stock symbol of SonoScape? | SonoScape trades under 300633 ticker. |
| When did SonoScape go public? | SonoScape went public in 2017. |
| Who are competitors of SonoScape? | SonoScape main competitors include Sinocare, Tandem Diabetes Care, Enovis, Daan Gene, AtriCure, AdaptHealth, NeoGenomics, Wandong Medical, Integra Lifesciences, VCANBIO. |
| What is the current market cap of SonoScape? | SonoScape's current market cap is $1B. |
| What is the current revenue of SonoScape? | SonoScape's last 12 months revenue is $360M. |
| What is the current revenue growth of SonoScape? | SonoScape revenue growth (NTM/LTM) is 15%. |
| What is the current EV/Revenue multiple of SonoScape? | Current revenue multiple of SonoScape is 3.1x. |
| What is the current EBITDA of SonoScape? | SonoScape's last 12 months EBITDA is $45M. |
| What is SonoScape's EBITDA margin? | SonoScape's last 12 months EBITDA margin is 13%. |
| What is the current EV/EBITDA multiple of SonoScape? | Current EBITDA multiple of SonoScape is 24.6x. |
| What is the current FCF of SonoScape? | SonoScape's last 12 months FCF is ($13M). |
| What is SonoScape's FCF margin? | SonoScape's last 12 months FCF margin is (4%). |
| What is the current EV/FCF multiple of SonoScape? | Current FCF multiple of SonoScape is (88.2x). |
| How many companies SonoScape has acquired to date? | SonoScape hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies SonoScape has invested to date? | SonoScape hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to SonoScape
Lists including SonoScape
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.